“…11 As a type of important plasmonic semiconductor, copper chalcogenide provides an alternative plateform for PTA removal of tumor cells in cancer therapy because of their controllable absorption in the NIR spectrum, low-cost fabrication, and acceptable cytotoxicity. For example, several polymorphs of nonstoichiometric Cu 2-x S compounds including Cu 2 S (chalcocite), Cu 1.94 S (djurleite), Cu 1.8 S (digenite), Cu 1.75 S (anilite) and CuS (covellite) are p-type semiconductors and exhibit a stoichiometry-dependent band gap 30,31 size-, geometry-, and phase-, dependence of LSPR related absorption properties in Cu 2-x Y nanocrystals have also been extensively investigated besides composition. For example, several polymorphs of nonstoichiometric Cu 2-x S compounds including Cu 2 S (chalcocite), Cu 1.94 S (djurleite), Cu 1.8 S (digenite), Cu 1.75 S (anilite) and CuS (covellite) are p-type semiconductors and exhibit a stoichiometry-dependent band gap 30,31 size-, geometry-, and phase-, dependence of LSPR related absorption properties in Cu 2-x Y nanocrystals have also been extensively investigated besides composition.…”